8-K: International Stem Cell Corp Annual Meeting Results

International Stem Cell Corporation stockholders elected four directors at the 2026 Annual Meeting held on June 11, 2026.

Summary

• The company held its Annual Meeting of Stockholders on June 11, 2026.
• Stockholders voted to elect four directors to serve until the 2027 Annual Meeting.
• Andrey Semechkin and Russell Kern were elected by holders of Series D Preferred Stock with 2,457,143 votes for each.
• Donald A. Wright and Paul V. Maier were elected by holders of all shares of stock with 9,288,444 and 9,288,500 votes respectively.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing confirming the successful execution of routine corporate governance.

Positives

• Successful completion of the Annual Meeting of Stockholders.
• All nominated director candidates were successfully elected to the board.

Negatives

• None identified in this filing.

Risks

• None identified in this filing.

Future Outlook

The elected directors will serve until the 2027 Annual Meeting.

Industry Context

StockSavvy.ai notes that this filing represents standard corporate governance procedures for a publicly traded biotechnology firm, ensuring board continuity and shareholder representation.

Comparison to Industry Standards

• The election process follows standard Delaware corporate law requirements for public companies.
• The voting structure involving Series D Preferred Stock is common in venture-backed or early-stage biotech firms.

Corporate Governance

Stakeholder Impact

• Shareholders have confirmed the board composition for the upcoming year.

Next Steps

• Directors to serve until the 2027 Annual Meeting.

Key Dates

Keywords

International Stem Cell Corporation, Annual Meeting, Director Election, Corporate Governance, Proxy Voting